{
  "@context": "aku-v2",
  "@type": "pharmacology",
  "@id": "vascular:pharmacology:anticoagulation:warfarin",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-07T00:53:00.000Z",
    "updated": "2026-01-07T00:53:00.000Z",
    "contributors": [
      "vascular-surgery-agent"
    ],
    "confidence": 0.95,
    "status": "enhanced",
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pharmacology",
    "type": "pharmacology",
    "difficulty": "intermediate",
    "importance": "high"
  },
  "content": {
    "identifier": "PHARM-005",
    "title": "Warfarin Anticoagulation",
    "definition": "Vitamin K antagonist anticoagulant used for prevention and treatment of thromboembolic disorders.",
    "concepts": [
      {
        "concept_id": "mechanism",
        "term": "Mechanism of Action",
        "definition": "Inhibits vitamin K epoxide reductase, preventing gamma-carboxylation of factors II, VII, IX, and X.",
        "clinical_features": {
          "affected_factors": [
            "Factor II (prothrombin)",
            "Factor VII",
            "Factor IX",
            "Factor X"
          ],
          "affected_proteins": [
            "Protein C",
            "Protein S"
          ],
          "onset": "Full effect 5-7 days due to factor half-lives"
        }
      },
      {
        "concept_id": "monitoring",
        "term": "INR Monitoring",
        "definition": "International Normalized Ratio for standardized warfarin monitoring.",
        "clinical_features": {
          "target_ranges": {
            "vte": "2.0-3.0",
            "mechanical_valve": "2.5-3.5",
            "af": "2.0-3.0"
          },
          "time_in_range": "Goal >65-70% TTR",
          "frequency": "Weekly until stable, then monthly"
        }
      },
      {
        "concept_id": "interactions",
        "term": "Drug and Food Interactions",
        "definition": "Extensive interactions affecting warfarin metabolism and vitamin K availability.",
        "clinical_features": {
          "potentiators": [
            "Amiodarone",
            "Fluconazole",
            "Metronidazole",
            "TMP-SMX",
            "Cranberry"
          ],
          "inhibitors": [
            "Rifampin",
            "Carbamazepine",
            "Phenytoin",
            "St. John's wort"
          ],
          "vitamin_k_foods": [
            "Leafy greens",
            "Liver",
            "Certain oils"
          ],
          "cyp2c9_cyp4f2": "Genetic polymorphisms affect dosing"
        }
      },
      {
        "concept_id": "reversal",
        "term": "Warfarin Reversal",
        "definition": "Strategies for reversing warfarin anticoagulation in bleeding or urgent surgery.",
        "clinical_features": {
          "vitamin_k": {
            "oral": "2.5-5 mg for elevated INR without bleeding",
            "iv": "10 mg for serious bleeding",
            "onset": "6-24 hours"
          },
          "4_factor_pcc": [
            "Immediate reversal",
            "25-50 units/kg based on INR",
            "Preferred over FFP"
          ],
          "ffp": "15 mL/kg if PCC unavailable"
        }
      }
    ],
    "clinical_features": {
      "bridge_therapy": "LMWH or UFH during initiation until INR therapeutic",
      "perioperative": "Hold 5 days pre-procedure for most surgeries"
    },
    "diagnostic_criteria": {
      "supratherapeutic": "INR >4 requires dose adjustment",
      "critical": "INR >10 requires vitamin K"
    },
    "statement": "Warfarin Anticoagulation is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pharmacology that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding Warfarin Anticoagulation helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of Warfarin Anticoagulation include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of Warfarin Anticoagulation."
    }
  },
  "relationships": [
    {
      "type": "alternative_to",
      "target": "vascular:pharmacology:doac"
    },
    {
      "type": "treats",
      "target": "vascular:pathology:venous:dvt"
    },
    {
      "type": "reversed_by",
      "target": "vascular:pharmacology:vitamin-k"
    }
  ],
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). Warfarin Anticoagulation. Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  }
}